STRS Ohio’s Apellis Pharmaceuticals APLS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $44.6K | Buy |
+2,577
| New | +$44.6K | ﹤0.01% | 2045 |
|
|
2024
Q3 | – | Sell |
-17,650
| Closed | -$677K | – | 1969 |
|
|
2024
Q2 | $677K | Buy |
+17,650
| New | +$677K | ﹤0.01% | 1038 |
|
|
2023
Q3 | – | Sell |
-7,521
| Closed | -$685K | – | 1938 |
|
|
2023
Q2 | $685K | Sell |
7,521
-4,679
| -38% | -$426K | ﹤0.01% | 1100 |
|
|
2023
Q1 | $804K | Buy |
12,200
+1,800
| +17% | +$119K | ﹤0.01% | 1039 |
|
|
2022
Q4 | $537K | Sell |
10,400
-2,500
| -19% | -$129K | ﹤0.01% | 1286 |
|
|
2022
Q3 | $881K | Buy |
12,900
+3,700
| +40% | +$253K | ﹤0.01% | 977 |
|
|
2022
Q2 | $416K | Buy |
9,200
+6,000
| +188% | +$271K | ﹤0.01% | 1409 |
|
|
2022
Q1 | $162K | Buy |
3,200
+100
| +3% | +$5.06K | ﹤0.01% | 1758 |
|
|
2021
Q4 | $146K | Sell |
3,100
-21,200
| -87% | -$998K | ﹤0.01% | 1813 |
|
|
2021
Q3 | $800K | Buy |
24,300
+8,300
| +52% | +$273K | ﹤0.01% | 1259 |
|
|
2021
Q2 | $1.01M | Buy |
+16,000
| New | +$1.01M | ﹤0.01% | 1159 |
|
|
2021
Q1 | – | Sell |
-3,400
| Closed | -$194K | – | 2173 |
|
|
2020
Q4 | $194K | Buy |
+3,400
| New | +$194K | ﹤0.01% | 1749 |
|
|
2020
Q3 | – | Sell |
-9,800
| Closed | -$320K | – | 2189 |
|
|
2020
Q2 | $320K | Sell |
9,800
-21,300
| -68% | -$696K | ﹤0.01% | 1509 |
|
|
2020
Q1 | $833K | Hold |
31,100
| – | – | ﹤0.01% | 802 |
|
|
2019
Q4 | $952K | Sell |
31,100
-2,700
| -8% | -$82.7K | ﹤0.01% | 940 |
|
|
2019
Q3 | $814K | Buy |
+33,800
| New | +$814K | ﹤0.01% | 897 |
|
|
2018
Q2 | – | Sell |
-3,100
| Closed | -$68K | – | 2117 |
|
|
2018
Q1 | $68K | Hold |
3,100
| – | – | ﹤0.01% | 1683 |
|
|
2017
Q4 | $67K | Buy |
+3,100
| New | +$67K | ﹤0.01% | 1696 |
|